“A Phase I Double Blind, Placebo-Controlled, Randomized Study Of The Safety And Immunogenicity Of An Adjuvanted Hiv-1 Gag-Pol-Nef Fusion Protein And Adenovirus 35 Gag-Rt-Int-Nef Vaccine In Healthy Hiv-Uninfected African Adults”. Plos One 10. Plos One: e0125954. http://www.ncbi.nlm.nih.gov/pubmed/25961283.
. 2015. “A Phase 2 Study To Evaluate The Safety And Immunogenicity Of A Recombinant Hiv Type 1 Vaccine Based On Adeno-Associated Virus”. Aids Res Hum Retroviruses 26. Aids Res Hum Retroviruses: 933-942. http://www.ncbi.nlm.nih.gov/pubmed/20666584.
. 2010. “A Phase 2 Study To Evaluate The Safety And Immunogenicity Of A Recombinant Adeno-Associated Virus Hiv Vaccine”. In Aids Vaccine 2007 Conference. Aids Vaccine 2007 Conference. Seattle, WA. http://www.vaccineenterprise.org/conference_archive/2007/index.html.
. 2007.